Block listing Interim Review

Summary by AI ^BETAClose X

Henderson Far East Income Limited has provided an interim review of its blocklisting, reporting a balance of 4,603,741 ordinary shares not yet issued or allotted as of December 5, 2025. During the period from May 7, 2025, to December 5, 2025, the company issued 16,595,000 ordinary shares, while its block scheme was increased by 20,000,000 shares. The previous balance of un-allotted securities stood at 1,198,741 ordinary shares.

Disclaimer*

Henderson Far East Income Limited

08 December 2025

JANUS HENDERSON FUND MANAGEMENT UK LIMITED

HENDERSON FAR EAST INCOME LIMITED

Legal Entity Identifier: 213800801QRE00380596

8 December 2025

Blocklisting interim review

Name of applicant:		Henderson Far East Income Limited
Legal Entity Identifier:		2138008DIQREOD38O596
Name of scheme:		GENERAL
Period of return:	From:	7 May 2025	To:	5 December 2025
Balance of un-allotted securities under scheme(s) from previous return:		1,198,741 ordinary shares
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		20,000,000
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		16,595,000 ordinary shares
Equals: Balance under scheme(s) not yet issued/allotted at end of period:		4,603,741 ordinary shares

Name of contact:	Colleen Sutcliffe
Telephone number of contact:	020 7818 5919

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END